Eagle Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eagle Pharmaceuticals

10/08/2022 11:42

* Eagle Pharmaceuticals Inc  EGRX.OQ  reported quarterly
adjusted
earnings of $1.56​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was
for earnings of $3.36 per share.
    * Revenue rose 54.1% to $74.14 million from a year ago;
analysts
expected $116.89 million. 
    * Eagle Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 74 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Eagle Pharmaceuticals Inc shares had fallen by 17.0% this
quarter and lost 27.6% so far this year.
    * The company reported a quarterly loss of $9.45 million.
    * Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $45.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 10:42 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      3.36           1.56           Missed
 Mar. 31 2022      3.88           4.04           Beat
 Dec. 31 2021      0.94           0.85           Missed
 Sep. 30 2021      0.83           0.56           Missed